title: Response to Iraqi and Hughes.
authors.affiliation: Duke Clinical Research Institute, School of Medicine, Duke University, Durham, North Carolina.|School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.
authors.forename: Edward Chia-Cheng
authors.initials: EC
authors.lastname: Lai
authors.affiliation: Geriatric Medicine Unit, Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Monera B
authors.initials: MB
authors.lastname: Wong
authors.affiliation: Health Outcome Research Center, National Cheng Kung University, Tainan, Taiwan.|Division of Geriatric Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
authors.forename: Isao
authors.initials: I
authors.lastname: Iwata
authors.affiliation: Duke Clinical Research Institute, School of Medicine, Duke University, Durham, North Carolina.
authors.forename: Yinghong
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.|Department of Neurology, Tainan Sin-Lau Hospital, Tainan, Taiwan.
authors.forename: Cheng-Yang
authors.initials: CY
authors.lastname: Hsieh
authors.affiliation: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.|Health Outcome Research Center, National Cheng Kung University, Tainan, Taiwan.
authors.forename: Yea-Huei Kao
authors.initials: YH
authors.lastname: Yang
authors.affiliation: Duke Clinical Research Institute, Department of Medicine, School of Medicine, Duke University, Durham, North Carolina.
authors.forename: Soko
authors.initials: S
authors.lastname: Setoguchi
mesh_terms: D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D003704:Dementia / Q000188:drug therapy*; D005260:Female; D005702:Galantamine / Q000009:adverse effects*; D006801:Humans; D007189:Indans / Q000009:adverse effects*; D008297:Male; D048448:Phenylcarbamates / Q000009:adverse effects*; D010880:Piperidines / Q000009:adverse effects*; D011014:Pneumonia / Q000139:chemically induced* / Q000453:epidemiology*
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D005702:Galantamine